Results give advantage to Boehringer/Lilly’s Jardiance.
Chiesi takes on Seretide and other lung drugs with Trimbow.
Italian pharma gets EU rights to Seloken.
Contrasting fortunes for Roche and AZ in a week of drama.
AZ waits for second set of results due later this year.
AZ hopes for blockbuster sales from Imfinzi.
Building not operational until 2019, says CEO